^
Association details:
Biomarker:No biomarker
Cancer:Burkitt Lymphoma
Drug:Rituxan (rituximab) (CD20 inhibitor)
Regimen:CODOX-M (cyclophosphamide + cytarabine + doxorubicin hydrochloride + + vincristine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
AIDS-related B-cell lymphomas: treatment…burkitt lymphoma…suggested regimens…preferred regimens…CODOX-M/IVAC (modified): cyclophosphamide, vincristine, doxorubicine, high-dose methotrexate alternating with ifosfamide, etoposide, high-dose cytrabine + rituximab